One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Kestra Medical Techs just hit that mark, with a jump from 77 to 85 Friday.
IBD's proprietary rating measures share price movement with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the trailing 52 weeks compares to all the other stocks in our database.
History shows that the stocks that go on to make the biggest gains tend to have an RS Rating north of 80 as they launch their biggest runs.
Looking For The Best Stocks To Buy And Watch? Start Here
While Kestra Medical Techs is not near a proper buy point right now, see if it goes on to form and break out from a proper chart pattern.
Kestra Medical Techs showed 0% earnings growth last quarter. Revenue rose 193%.
Kestra Medical Techs holds the No. 36 rank among its peers in the Medical-Products industry group. Boston Scientific, Pro-Dex and Penumbra are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
